Redasemtide
Highest phase reached
Phase 2
Drug type
Protein
- Listing at source
- Listed
- Highest phase reached
- Phase 2
- Drug type
- Protein
- Drug name
- Redasemtide
- redasemtide
- Redasemtide
- redasemtide [INN]
- Redasemtide [WHO-DD]
- redasemtide inn
- redasemtide who dd
- s 005151
- S-005151
- CAS registry numbers
- 1606186-88-2
- ChEMBL ID
- CHEMBL6068588
- FDA ingredient codes (UNII)
- OVE619G496
- First in class
- No
- Orphan designation
- No
- Drug name stem
- -tide
Investigated indications
- Condition
- Stroke
- Highest recorded phase
- 2
- Condition identifier
- EFO:0000712
- Subject identifier
- D020521
Open Targets indications
- Condition identifier
- MONDO_1060198
- Highest recorded phase
- 2
Trial references
- NCT05953480
- Prodrug
- No
- Chirality
- Single enantiomer
- Inorganic
- No
- Natural product
- No
Related records
Trials (1)
In development for (1)
- Stroke disorder Phase 2